Carcinoma of unknown primary - rare but ripe for help from genomics?

摘要: The treatment of most cancer patients is based on first determining where the arose anatomically - lung, breast, prostate and so on. For a group with disseminated disease, this crucial starting point missing. Carcinoma or adenocarcinoma unknown primary diagnosis made likely site origin cannot be detected. Here we describe use molecular genetic tests to improve both identification for carcinoma possible novel options presence specific mutations. We outline Solving Unknown Primary Cancer study, which aimed at utility testing in primary.